UDG Healthcare Public Limited Co. Notice of Preliminary Results (1671G)

TIDMUDG

RNS Number : 1671G

UDG Healthcare Public Limited Co.

02 November 2018

2 November 2018

UDG Healthcare plc

Notice of Preliminary Results

UDG Healthcare plc ("the Group"), a leading international healthcare services provider, will issue its full year results for the year ending 30 September 2018 at 07:00am (GMT) on Tuesday 27 November 2018.

Brendan McAtamney, Chief Executive Officer, and Nigel Clerkin, Chief Financial Officer, will be hosting a presentation for analysts and investors at the London Stock Exchange at 08:30am (GMT) to discuss the company's full year results and provide an update on each of the Group's divisions. They will be joined for a Q&A session by other members of the divisional management team.

Analysts and investors wishing to attend are asked to contact Powerscourt on the details below, as all attendees need to be pre-registered. The presentation will also be available via live audio webcast and conference call, the details of which are below.

Audio webcast:

https://edge.media-server.com/m6/p/njnoc85w

Conference call dial-in details:

 
 UK                          [phone] 
 Ireland                     [phone] 
                            -------------------- 
 United States of America    [phone] 
                            -------------------- 
 Participant Code            7295026 
                            -------------------- 
 

For further information, please contact:

 
 UDG Healthcare plc 
  Keith Byrne 
 Head of Investor Relations, Strategy & Corporate 
  Communications 
 Tel: [phone] 
 
 Powerscourt 
 Lisa Kavanagh / Jana Tsiligiannis / Sam Austrums 
 Tel: [phone] 
  [e-mail] 
 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries.

It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of-the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NORKMMGMRZKGRZG

(END) Dow Jones Newswires

November 02, 2018 04:59 ET (08:59 GMT)